Since the ligand activity was tested at physiological concentrations, we can conclude two things—IGF-1 and IGF–1R interaction may be responsible for the increased metabolic activity of BC cells, and these cells rely on the glycolytic pathway to increase ATP production and meet the metabolic demand for proliferation. The gene discussed is IGF1; the disease is breast cancer.